4//SEC Filing
INVIVO THERAPEUTICS HOLDINGS CORP. 4
Accession 0001179110-15-016170
CIK 0001292519operating
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:24 PM ET
Size
5.5 KB
Accession
0001179110-15-016170
Insider Transaction Report
Form 4
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
Stock Option (Right To Buy)
2015-12-10+115,050→ 115,050 totalExercise: $7.37Exp: 2025-12-10→ Common Stock (115,050 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.
Documents
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK 0001292519
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001292519
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:24 PM ET
- Size
- 5.5 KB